Stockreport

Unit Of Li Ka-Shing's CK Life Sciences To Merge With Nasdaq-Listed Biotech Company In $100 Million Deal [Forbes]

CK HUTCH HLD LTD UNSP/ADR  (CKHUY) 
NASDAQ:AMEX Investor Relations: ckh.com.hk/en/ir
PDF Li Ka-shing, senior advisor of CK Hutchison, which controls CK Life Sciences. Li Ka Shing Foundation CK Life Sciences, the biotech arm of Hong Kong billionaire Li K [Read more]